Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2015

01-12-2015 | Letter

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!

Published in: Critical Care | Issue 1/2015

Login to get access

Excerpt

We read with great interest the paper by Schilder and colleagues on citrate anticoagulation versus systemic heparinisation (CASH) [1] and its related commentary [2], but would like to comment on two important metabolic issues. …
Literature
1.
Schilder L, Nurmohamed SA, Bosch FH, Purmer IM, den Boer SS, Kleppe CG, et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Crit Care. 2014;18:472.CrossRef
2.
Oudemans-van Straaten HM. Citrate for continuous renal replacement therapy: safer, better and cheaper. Crit Care. 2014;18:661.CrossRef
3.
Jacobs R, Honoré PM, De Regt J, De Waele E, Lochy S, Troubleyn J, et al. Type of citrate solution and filter lifespan during continuous renal replacement therapy [abstract]. Intensive Care Med. 2013;39:S442–3.
4.
Jacobs R, Honore PM, De Regt J, de Mars M, Spapen HD. Citrate during CRRT. In: Vuylsteke A, editor. Renal replacement therapy – core critical care. Cambridge, UK: Cambridge University Press; 2015. In press.
5.
Egi M, Naka T, Bellomo R. The acid–base effect of changing citrate solution for regional anticoagulation during continuous veno-venous hemofiltration. Int J Artif Organs. 2008;31:228–36.CrossRef
Metadata
Title
Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
Publication date
01-12-2015
Published in
Critical Care / Issue 1/2015
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-015-0766-3

Other articles of this Issue 1/2015

Critical Care 1/2015 Go to the issue

Research

Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study

Research

Associations between single nucleotide polymorphisms in the FAS pathway and acute kidney injury

Research

Platelet mitochondrial dysfunction in critically ill patients: comparison between sepsis and cardiogenic shock

Research

A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: a prospective open label study

Research

Management and outcome of mechanically ventilated patients after cardiac arrest

Research

Inflammatory mediators in intra-abdominal sepsis or injury – a scoping review